Introduction
Chronic kidney disease encompasses a spectrum of different pathophysiological process and is defined as abnormalities of kidney structure or function, present for >3 months, with implications for health 10% of the population worldwide is affected by chronic kidney disease and millions die each year because they do not have access to affordable treatment. 1 According to the 2010
Global Burden of Disease study, chronic kidney disease was ranked 27th in the list of causes of total number of deaths worldwide in 1990, but rose to 18th in 2010. This degree of movement up the list was second only to that for HIV and AIDs.
2
Over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive, yet this number may only represent 10% of people who actually need treatment to live.
3
Cardiovascular disease is one of the leading causes of the morbidity and mortality in the chronic kidney disease. There is tremendous increase in the risk of cardiovascular disease as the severity of the chronic kidney disease increases. 
Results
In the present study majority of the patients were in the age group of 61-70 years, combined diabetes and hypertension was the leading cause of chronic kidney disease, followed by diabetes then hypertension in our study. Majority of patients in our study were distributed in moderate and severe CKD group, and majority of patient were in stage 5 of CKD based on creatinine clearance In our study 63% of patients had left ventricular hypertrophy with or without strain and 31% had no signs of left ventricular hypertrophy on ECG and ST-T changes were seen in 30% of patients On echocardiographic examination we observed 69% had left ventricular hypertrophy (48% concentric and 21% eccentric LVH), diastolic dysfunction was seen in 42% and systolic dysfunction in 20% and 20% is having pericardial effusion and 31% patients had normal ECHO Majority of severe and moderate CKD patients (89% and 71%respectively) developed LVH Majority of severe and moderate CKD patients developed systolic and diastolic dysfunctions Majority of moderate and severe CKD patients developed ST-T changes 
Discussion
In our study maximum patient 28(40) are from 61-70 years of age group and 21 patients (30%) are from 51-60 yrs of age group. in the study of BEHERA BK et al. 2017 November in which majority of patients were in the age group of 61-70 that included 41% of the patient4 IN our study there were 80% of the patient were distributed in moderate and severe ckd (40% in each group). 57% of patient were of moderate to severe CKD and 27% of patient of severe CKD In study done by MAHMOOD et al 5
In our study electrocardiographic changes in CKD 63% majority of the patient has left ventricular hypertrophy and 30% has ST-T changes, the study done by SALAMN SHAFI et al department of medicine Pakistan which has 41% of left ventricular hypertrophy and 23% ST-T changes 6 In our study in echocardiographic observation 69% develop LEFT VENTRICULAR HYPERTROPHY majority of those (48%) had concentric LVH and 42% of patient develops diastolic dysfunction and 14% develop systolic dysfunction. In study done by MUKESH LADDHA et al January 2014 in this study LVH was present in 74% and diastolic dysfunction in 61% and systolic dysfunction in 24%. Presence of LVH is associated with severe diastolic and systolic dysfunction 7 In our study in association of LVH with severity of CKD 89% of LVH was found in severe case of CKD and 71% of LVH was found in moderate CKD. The study done by SUSHANT KUMAR et al Dec 2014 in severe CKD 88% had LVH, in moderate CKD 51% had LVH. It suggests as the severity of CKD increases increase of LVH incidence occur 8
Conclusion
There is high prevalence of left ventricular hypertrophy among CKD patients this implies that these patients require detail cardiovascular examination in absence of the cardiac symptoms and efforts should be aimed at prevention and control of these diseases
